Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
-
Authors :
Peters SAE; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands .; The George Institute for Global Health, School of Public Health, Imperial College London, London, UK.
Subjects: Heart* ; Coronary Artery Disease*; Humans
-
Source:
Heart (British Cardiac Society) [Heart] 2024 Jan 10; Vol. 110 (3), pp. 149-150. Date of Electronic Publication: 2024 Jan 10.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Hui Z; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China.; Zhongs School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/diagnosis; Humans
-
Source:
The British journal of ophthalmology [Br J Ophthalmol] 2023 Dec 18; Vol. 108 (1), pp. 84-90. Date of Electronic Publication: 2023 Dec 18.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Lexchin J; School of Health Policy and Management, York University - Keele Campus, Toronto, Ontario, Canada .; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/adverse effects
-
Source:
Drug and therapeutics bulletin [Drug Ther Bull] 2023 Nov 29; Vol. 61 (12), pp. 182-188. Date of Electronic Publication: 2023 Nov 29.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0112037 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Wang W; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, People's Republic of China.; Cheng W
Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications; Humans
-
Source:
The British journal of ophthalmology [Br J Ophthalmol] 2023 Sep; Vol. 107 (9), pp. 1319-1323. Date of Electronic Publication: 2022 May 16.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Parkinson B; Health, Organisation, Policy and Economics Research Group, Centre for Primary Care and Health Services Research, The University of Manchester, Manchester, UK .; McManus E
Subjects: General Practice* ; Diabetes Mellitus, Type 2*; Humans
-
Source:
BMJ quality & safety [BMJ Qual Saf] 2023 May; Vol. 32 (5), pp. 274-285. Date of Electronic Publication: 2022 Dec 06.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101546984 Publication Model: Print-Electronic Cited Medium:
Record details